PMID- 33330652 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220107 IS - 2297-055X (Print) IS - 2297-055X (Electronic) IS - 2297-055X (Linking) VI - 7 DP - 2020 TI - Ideal Cardiovascular Health Metrics and Incidence of Ischemic Stroke Among Hypertensive Patients: A Prospective Cohort Study. PG - 590809 LID - 10.3389/fcvm.2020.590809 [doi] LID - 590809 AB - Background: This study aimed to assess the relationship between ideal cardiovascular health (CVH) metrics and incident ischemic stroke (IS) in hypertensive patients, especially those with hyperhomocysteinemia (HHcy). Methods: A prospective cohort study enrolled 5,488 hypertensive patients in Nanshan District of Shenzhen City in southern China from September 2011 to December 2017. CVH metrics were defined according to the American Heart Association. Cox proportional hazards models were used to examine the associations between the number of ideal CVH metrics and the incidence of IS by calculating multivariable-adjusted hazard ratios (HRs) and 95% CI. Results: During an average follow-up of 5.7 years, 340 IS patients were identified. Compared with those having 0 ideal CVH metrics, the HRs (95% CIs) for IS among those with 1, 2, 3, 4, and 5-6 ideal CVH metrics were 0.62 (0.31-1.25), 0.37 (0.19-0.74), 0.37 (0.18-0.74), 0.34 (0.16-0.71), and 0.28 (0.12-0.63), respectively (P < 0.001). An ideal healthy diet score and ideal fasting blood glucose level were independently associated with IS among participants, with HRs (95% CIs) of 0.53 (0.33-0.86) and 0.32 (0.17-0.66), respectively. Additionally, compared with those with normal total homocysteine (tHcy) levels (<15 mumol/L), the HR (95% CI) for IS among participants with HHcy and who had 5-6 ideal CVH metrics was 0.50 (0.27-0.92). Conclusion: An increased number of ideal CVH metrics was inversely associated with the incidence of IS in hypertensive patients. The participants with HHcy who had 5-6 ideal CVH metrics exhibited a lower IS risk than those with normal tHcy levels. CI - Copyright (c) 2020 Ying, Lin, Kong, Li, Xu, Liang, Wang and Han. FAU - Ying, Yuchen AU - Ying Y AD - Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, China. FAU - Lin, Shaoyi AU - Lin S AD - Cardiology Department, Ningbo First Hospital, Ningbo, China. FAU - Kong, Fanqian AU - Kong F AD - Department of Medical Record and Statistics, Ningbo Medical Center Lihuili Hospital, Ningbo, China. FAU - Li, Yuying AU - Li Y AD - Shenzhen Polytechnic, Shenzhen, China. FAU - Xu, Shujun AU - Xu S AD - Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, China. FAU - Liang, Xiaofeng AU - Liang X AD - Chinese Preventive Medicine Association, Beijing, China. FAU - Wang, Changyi AU - Wang C AD - Department of Chronic Disease Prevention and Control, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China. FAU - Han, Liyuan AU - Han L AD - Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China. AD - Department of Global Health, Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China. LA - eng PT - Journal Article DEP - 20201123 PL - Switzerland TA - Front Cardiovasc Med JT - Frontiers in cardiovascular medicine JID - 101653388 EIN - Front Cardiovasc Med. 2021 Dec 21;8:829078. PMID: 34993243 PMC - PMC7719670 OTO - NOTNLM OT - hyperhomocysteinemia OT - hypertensive patients OT - ideal cardiovascular health metrics OT - ischemic stroke OT - prospective study EDAT- 2020/12/18 06:00 MHDA- 2020/12/18 06:01 PMCR- 2020/01/01 CRDT- 2020/12/17 05:54 PHST- 2020/08/03 00:00 [received] PHST- 2020/09/29 00:00 [accepted] PHST- 2020/12/17 05:54 [entrez] PHST- 2020/12/18 06:00 [pubmed] PHST- 2020/12/18 06:01 [medline] PHST- 2020/01/01 00:00 [pmc-release] AID - 10.3389/fcvm.2020.590809 [doi] PST - epublish SO - Front Cardiovasc Med. 2020 Nov 23;7:590809. doi: 10.3389/fcvm.2020.590809. eCollection 2020.